The Need for Artificial Intelligence in Digital Therapeutics.
Artificial intelligence
Digital biomarkers
Digital medicine
Digital therapeutics
Machine learning
Precision medicine
Journal
Digital biomarkers
ISSN: 2504-110X
Titre abrégé: Digit Biomark
Pays: Switzerland
ID NLM: 101707633
Informations de publication
Date de publication:
Historique:
received:
17
01
2020
accepted:
28
02
2020
entrez:
14
5
2020
pubmed:
14
5
2020
medline:
14
5
2020
Statut:
epublish
Résumé
Digital therapeutics is a newly described concept in healthcare which is proposed to change patient behavior and treat medical conditions using a variety of digital technologies. However, the term is rarely defined with criteria that make it distinct from simply
Identifiants
pubmed: 32399513
doi: 10.1159/000506861
pii: dib-0004-0021
pmc: PMC7204774
doi:
Types de publication
Journal Article
Langues
eng
Pagination
21-25Informations de copyright
Copyright © 2020 by S. Karger AG, Basel.
Déclaration de conflit d'intérêts
The authors declare that they have no conflicts of interest.
Références
Diabetes Care. 2014;37(5):1191-7
pubmed: 24757226
J Clin Transl Sci. 2017 Dec;1(6):373-380
pubmed: 29707260
Diabetes Technol Ther. 2013 May;15(5):386-400
pubmed: 23544672
Digit Biomark. 2017 Aug 17;1(1):73-81
pubmed: 32095747
Lancet Psychiatry. 2018 Aug;5(8):625-632
pubmed: 30007519
NPJ Digit Med. 2018 Jan 15;1:20172
pubmed: 31304346
Clin Pharmacol Ther. 2018 Jul;104(1):72-80
pubmed: 29377057
Per Med. 2018 Sep;15(5):429-448
pubmed: 30259801
JAMA. 2015 Feb 3;313(5):459-60
pubmed: 25569175
JAMA. 2016 Oct 4;316(13):1407-1408
pubmed: 27629148
Trials. 2019 Jan 29;20(1):87
pubmed: 30696471
Health Aff (Millwood). 2018 May;37(5):694-701
pubmed: 29733705